Huntsman Cancer Institute brought together top researchers from across the country to address how artificial intelligence and other technologies will innovate cancer prevention and care delivery—particularly for rural patients.
Their innovative research, supported by federal funding, shape the future of cancer care, from using digital communications to better access genetic services to increasing medicine’s effectiveness while lessening side effects.
A novel oral combination drug therapy evaluated at Huntsman Cancer Institute could treat and prevent melanoma spreading to the brain. Brain metastasis is the main cause of death from melanoma.
Physician-scientist Conan Kinsey gives three reasons why pancreatic cancer has one of the lowest survival rates for any kind of cancer and explains how federally and donor-funded research provides hope.
Genomic analyses funded by the National Cancer Institute show that ovarian cancer mutations are nearly identical across populations, yet some differences emerged. This information may be relevant for treatment decisions.
These awards advance cancer research, support scientists, and establish a training program for students. The funding underscores a commitment to future cancer investigators and better patient outcomes.
Three executive leaders describe how they see Huntsman Cancer Institute advancing cancer care and research in 2025 and beyond, including increasing cancer care access for all.
Cancer research and care have advanced dramatically, saving lives through innovation and dedication. A new facility will expand access and fuel discoveries, bringing hope and progress to more communities.
The HCI-UVU Health Collaborative offers interns hands-on research, cancer center professional services, and clinical volunteer services to prepare students for impactful careers in cancer research and health care.
Surgeon General Vivek Murthy released an advisory to increase public awareness that alcohol use can increase the risk of cancer, as only 45% of Americans are aware of the connection.
Gita Suneja, MD, MSHP, shares her personal cancer story, her passion for fostering future researchers and investigators, and the importance of being an advocate for cancer patients.
The introduction of two da Vinci 5 systems enhances surgery precision and decreases recovery times for patients. This strengthens Huntsman Cancer Institute’s role as a leader in robotic surgical care.
As director of Huntsman Cancer Institute’s biorepository, Filmore and his team advance cancer care by collecting patient samples, unraveling molecular mysteries, and assisting in the creation of innovative treatments.
Huntsman Cancer Institute joins with other institutions through myeloMATCH, a program that matches patients with clinical trials that specifically target their Сòòò½APP.
Huntsman Cancer Institute researchers have identified a gene variant found in a high-altitude Andean population that may predict severity of Сòòò½APPs and responses to treatments for patients with certain types...
